Sector updates in April

/in
< 1 minute read

Investment firms 

  • Andrew Fergurson retired from Baird Capital 
  • Regina Hodits appointed Managing Director at Angelini Ventures 
  • Paula Olazabal left her role as Partner and Head of ESG at Ysios Capital and is now an External and Strategic Financial Advisor  
  • Morgan Cheatham joins Breyer Capital as Partner and Head of Healthcare and Life Sciences  

Media    

  • Discover Pharma, a new independent pharma news platform, launches with Liza Laws as Editor-in-Chief 
  • Bioinsights Publishing Ltd, launches Bioconjugation Insights – a peer-reviewed, Open Access Publication highlighting the latest news, trends, challenges, and breakthroughs at the intersection of biology and chemistry 
  • Sarah Passey left her role as Senior Editor at The Lancet Neurology and has been appointed Deputy Editor at The Lancet Obstetrics, Gynaecology, & Women’s Health 
  • Tom Nugent promoted to Managing Editor at Sifted 
  • Sarah Owermohle left her role as Healthcare Reporter at STAT and has been appointed Healthy Policy and Politics Reporter at CNN.com (US) 
  • Costanza Pearce promoted to Deputy Editor at Chemist + Druggist 
  • Natasha Lomas left her role as a Senior Reporter at TechCrunch and there is no news on her next role 
  • Rebecca Whittaker left her role as Health Features Writer at the Mail Online and has been appointed as General Reporter at The Independent 
  • Jessica Nangle left her role as Commercial Content Editor at Real Deals and there is no news of her next role 
  • Patrick Brusnahan appointed News Editor at Investment Week 
  • Pieter Snepvangers appointed Money Reporter at The Daily Telegraph 
  • Lydia Hawken has left her role as Senior Writer at Femail to go freelance 
  • Simon Hunt appointed City Editor at City A.M.